Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3,453,175
-
Shares change
-
+220,342
-
Total reported value, excl. options
-
$26,693,413
-
Value change
-
+$1,831,681
-
Number of buys
-
13
-
Number of sells
-
18
-
Price
-
$7.73
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2019
As of 31 Mar 2019 Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,453,175 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, SPHERA FUNDS MANAGEMENT LTD., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Sigma Planning Corp.
This table shows 40 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.